<table id="id_1b61c259-30d1-4c65-a716-63faffffd92c" width="429.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_0d8c73c1-6cba-4d06-ab0c-20075b28cc84">Table 2. Pharmacokinetic Parameters of Linezolid in Pediatrics and Adults Following a Single Intravenous Infusion of 10 mg/kg or 600 mg Linezolid (Mean: (%CV; [Min, Max Values])</caption>
<col align="left" width="30.1%"></col>
<col align="center" width="14.0%"></col>
<col align="center" width="14.0%"></col>
<col align="center" width="14.0%"></col>
<col align="center" width="14.0%"></col>
<col align="center" width="14.0%"></col>
<thead>
<tr id="id_3ea3081c-3cb7-473f-a44d-e5e56f5ebd21">
<td align="left" stylecode="Botrule Rrule" valign="top">
<br/>Age Group</td>
<td align="left" stylecode="Rrule" valign="top">C<sub>max</sub>
<br/>µg/mL</td>
<td align="left" stylecode="Rrule" valign="top">V<sub>ss</sub>
<br/>L/kg</td>
<td align="left" stylecode="Rrule" valign="top">AUC <footnote id="id-55c761f8-f31a-4b15-84b1-861507224edc">AUC = Single dose AUC<sub>0–∞</sub>
</footnote>
<br/>µg • h/mL</td>
<td align="left" stylecode="Rrule" valign="top">t<sub>1/2</sub>
<br/>hrs</td>
<td align="left" stylecode="Botrule" valign="top">CL<br/>mL/min/kg</td>
</tr>
</thead>
<tfoot id="id_389bd389-ecfd-4436-8827-01dff4884a30">
<tr>
<td align="left" colspan="6" stylecode="Lrule Botrule" valign="top">C<sub>max</sub> = Maximum plasma concentration; V<sub>ss=</sub> Volume of distribution; AUC = Area under concentration-time curve; t<sub>1/2</sub> = Apparent elimination half-life; CL = Systemic clearance normalized for body weight</td>
</tr>
</tfoot>
<tbody>
<tr id="id_66afa693-f63a-4813-8bfe-34b3d98d2f0d">
<td align="left" stylecode="Toprule Botrule" valign="top">Neonatal Patients<br/>  Pre-term<footnote id="id-fe417405-d0a5-406c-9f0c-8ab6a34deb39">In this data set, "pre-term" is defined as &lt;34 weeks gestational age (Note: Only 1 patient enrolled was pre-term with a postnatal age between 1 week and 28 days)</footnote>
<br/>  &lt; 1 week (N=9)<footnote id="id-42f1e146-693e-4319-88ce-30b383829476">Dose of 10 mg/kg</footnote>
</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>12.7 (30%)<br/>[9.6, 22.2]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>0.81 (24%)<br/>[0.43, 1.05]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>108 (47%)<br/>[41, 191]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>5.6 (46%)<br/>[2.4, 9.8]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>2.0 (52%)<br/>[0.9, 4.0]</td>
</tr>
<tr id="id_e1e6a935-4747-4f46-be49-ce5ddc6c0554">
<td align="left" stylecode="Botrule" valign="top">  Full-term<footnote id="id-483bd0f3-a073-42c3-b89b-b72f7e8df491">In this data set, "full-term" is defined as ≥34 weeks gestational age</footnote>
<br/>  &lt; 1 week (N=10)<footnoteref idref="id-42f1e146-693e-4319-88ce-30b383829476"></footnoteref>
</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>11.5 (24%)<br/>[8.0, 18.3]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>0.78 (20%)<br/>[0.45, 0.96]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>55 (47%)<br/>[19, 103]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>3.0 (55%)<br/>[1.3, 6.1]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>3.8 (55%)<br/>[1.5, 8.8]</td>
</tr>
<tr id="id_88e5037e-b784-4ef3-a25d-83f8968ea869">
<td align="left" stylecode="Botrule" valign="top">  Full-term<footnoteref idref="id-483bd0f3-a073-42c3-b89b-b72f7e8df491"></footnoteref>
<br/>  ≥ 1 week to ≤ 28 days (N=10)<footnoteref idref="id-42f1e146-693e-4319-88ce-30b383829476"></footnoteref>
</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>12.9 (28%)<br/>[7.7, 21.6]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>0.66 (29%)<br/>[0.35, 1.06]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>34 (21%)<br/>[23, 50]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>1.5 (17%)<br/>[1.2, 1.9]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>5.1 (22%)<br/>[3.3, 7.2]</td>
</tr>
<tr id="id_c81d09b5-fa43-4ef1-97b3-56e1631601d4">
<td align="left" stylecode="Botrule" valign="top">Infant Patients<br/>  &gt; 28 days to &lt; 3 Months (N=12 )<footnoteref idref="id-42f1e146-693e-4319-88ce-30b383829476"></footnoteref>
</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>11.0 (27%)<br/>[7.2, 18.0]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>0.79 (26%)<br/>[0.42, 1.08]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>33 (26%)<br/>[17, 48]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>1.8 (28%)<br/>[1.2, 2.8]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>5.4 (32%)<br/>[3.5, 9.9]</td>
</tr>
<tr id="id_91cf67a5-c1eb-4f3a-997b-2e48d7535361">
<td align="left" stylecode="Botrule" valign="top">Pediatric Patients<br/>  3 months through 11 years<footnoteref idref="id-42f1e146-693e-4319-88ce-30b383829476"></footnoteref> (N=59)</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>15.1 (30%)<br/>[6.8, 36.7]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>0.69 (28%)<br/>[0.31, 1.50]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>58 (54%)<br/>[19, 153]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>2.9 (53%)<br/>[0.9, 8.0]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>3.8 (53%)<br/>[1.0, 8.5]</td>
</tr>
<tr id="id_46caf56a-0e63-4319-b068-86dc68769afb">
<td align="left" stylecode="Botrule" valign="top">Adolescent Subjects and Patients<br/>  12 through 17 years<footnote id="id-dc48ae19-2e25-4d7c-9872-7a0ad663ed02">Dose of 600 mg or 10 mg/kg up to a maximum of 600 mg</footnote> (N=36)</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>16.7 (24%)<br/>[9.9, 28.9]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>0.61 (15%)<br/>[0.44, 0.79]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>95 (44%)<br/>[32, 178]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>4.1 (46%)<br/>[1.3, 8.1]</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>2.1 (53%)<br/>[0.9, 5.2]</td>
</tr>
<tr id="id_d2d32c9c-3a72-4fa9-9759-c89db5c3e106">
<td align="left" stylecode="Botrule" valign="top">Adult Subjects<footnote id="id-8cccfaf9-e4b7-40ef-a3f9-dd5dacd9f20b">Dose normalized to 600 mg</footnote> (N= 29)</td>
<td align="left" stylecode="Botrule" valign="top">12.5 (21%)<br/>[8.2, 19.3]</td>
<td align="left" stylecode="Botrule" valign="top">0.65 (16%)<br/>[0.45, 0.84]</td>
<td align="left" stylecode="Botrule" valign="top">91 (33%)<br/>[53, 155]</td>
<td align="left" stylecode="Botrule" valign="top">4.9 (35%)<br/>[1.8, 8.3]</td>
<td align="left" stylecode="Botrule" valign="top">1.7 (34%)<br/>[0.9, 3.3]</td>
</tr>
</tbody>
</table>